Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial

Journal:

Nature Communications

Published:

2025-05-13

DOI:

10.1038/s41467-025-59151-0

Affiliations:

36

Authors:

49

Go to article

Institutions	Authors	Share
AstraZeneca UK Limited, United Kingdom (UK)	8.000000	0.16
Cambridge University Hospitals NHS Foundation Trust, United Kingdom (UK)	6.000000	0.12
University of Cambridge, United Kingdom (UK)	5.500000	0.11
Cancer Research UK Cambridge Institute (CRUK-CI), University of Cambridge, United Kingdom (UK)	2.500000	0.05
Addenbrooke's Hospital, United Kingdom (UK)	2.000000	0.04
Athens University of Economics and Business (AUEB), Greece	1.000000	0.02
Royal Devon University Healthcare NHS Foundation Trust, United Kingdom (UK)	1.000000	0.02
Royal Bournemouth Hospital, United Kingdom (UK)	1.000000	0.02
Ipswich Hospital, United Kingdom (UK)	1.000000	0.02
University Hospitals Dorset NHS Foundation Trust, United Kingdom (UK)	1.000000	0.02
ApconiX Ltd., United Kingdom (UK)	1.000000	0.02
University Hospitals of Derby and Burton NHS Foundation Trust, United Kingdom (UK)	1.000000	0.02
Bedford Hospital, United Kingdom (UK)	1.000000	0.02
Velindre Cancer Centre, Velindre NHS Trust, United Kingdom (UK)	1.000000	0.02
University Hospitals Bristol and Weston NHS Foundation Trust (UHBW NHS), United Kingdom (UK)	1.000000	0.02
BHRUT Queen's Hospital, United Kingdom (UK)	1.000000	0.02
Beatson West of Scotland Cancer Centre (BWoSCC), United Kingdom (UK)	1.000000	0.02
Hinchingbrooke Hospital, United Kingdom (UK)	1.000000	0.02
West Suffolk NHS Foundation Trust, United Kingdom (UK)	1.000000	0.02
Worcestershire Acute Hospitals NHS Trust, United Kingdom (UK)	1.000000	0.02
Colchester General Hospital, East Suffolk and North Essex NHS Foundation Trust, United Kingdom (UK)	1.000000	0.02
University College London Hospitals NHS Foundation Trust (UCLH), United Kingdom (UK)	1.000000	0.02
Oxford University Hospitals NHS Trust (OUH), United Kingdom (UK)	1.000000	0.02
Peterborough City Hospital, United Kingdom (UK)	1.000000	0.02
The Christie NHS Foundation Trust, United Kingdom (UK)	1.000000	0.02
University of Southampton (Soton), United Kingdom (UK)	1.000000	0.02
EMC2 Clinical Consultancy, United Kingdom (UK)	1.000000	0.02
NIHR Cambridge Biomedical Research Centre (Cambridge BRC), United Kingdom (UK)	1.000000	0.02
Nottingham City Hospital, NUH, United Kingdom (UK)	0.500000	0.01
The University of Nottingham (UoN), United Kingdom (UK)	0.500000	0.01
University Hospital Southampton NHS Foundation Trust, United Kingdom (UK)	0.500000	0.01
Hampshire Hospitals NHS Foundation Trust, United Kingdom (UK)	0.500000	0.01

Interested in Oncology and Carcinogenesis?